Innovative coating solutions created through science

Our technologies are rooted in over a decade of nanotechnology research at the University of Twente validated through 20+ awards, competitive EU and Dutch innovation grants, and active R&D partnerships with global medtech companies.

R&D

From lab towards (pre) clinical validation

LipoCoat works intensively with medical multinationals, academic institutions, and clinical partners to develop and validate new applications.

Become a partner

Sponsors and Research partners

Milestones

A track record of grant and investor validation

From an academic lipid-bilayer discovery to EU-backed clinical trials — a decade of grants, awards, and research partnerships that validated the science.

View our technology

Facilities

2015

Wins NanoNextNL "Dragon's Den" and NanoLabNL research voucher

2017

Secures €600K seed funding to develop the coating platform

2019

Named European Biotech Startup of the Year

2020

Secures €1.5M funding round (High Tech Fund Enschede, Innovation Fund Rabobank, informal investors); named Best Medical Device Coatings Company

2022

Partners with CEMMA Medical on a coated CVC catheter; wins Extreme Tech Challenge finalist spot

2025

Launches UROCOAT project with Health~Holland and University of Twente to develop an antibiotic-free catheter coating

Publication

SonoCoat® Technology Featured in Scientific Publications

Four independent peer-reviewed studies have evaluated SonoCoat®, from EUS-FNA needles to prostate brachytherapy. What each one tested, and what it found.

Read

Publication

Document

When the Needle Disappears: SonoCoat® in Three Clinical Applications

Real-time ultrasound guidance is now standard for CVC placement, yet needles still vanish at steep insertion angles. What SonoCoat® changes in vascular access, biopsy and regional anesthesia.